Cryoport Systems Awarded With 2026 European Healthcare & Pharmaceutical Supply Chain Excellence Award for Elevating Global Advanced Therapy Logistics
Cryoport Systems was recently honored with the Healthcare & Pharmaceutical Supply Chain Excellence Award at the 2026 European Supply Chain Excellence Awards. The industry-leading program has been recognizing best practices in European supply chain management for the past 30 years, with an experienced panel of judges bringing operational expertise across sectors.
The Healthcare & Pharmaceutical Supply Chain Excellence Award recognizes life sciences organizations whose work has contributed to improving patient outcomes through operational excellence. Cryoport Systems earned this award for being the first global supply chain provider to achieve ISO 21973 certification and its role in developing the international standard for the transportation of human cells intended for therapeutic use.
The advanced therapy industry previously lacked a cohesive, transportation standard for time- and temperature-sensitive materials. Many countries had established their own regulatory expectations, although none were fully aligned, causing supply chain practices to differ widely. This variation resulted in higher costs, operational burdens, and ultimately put irreplaceable materials at risk. And given how the advanced therapy market continues to grow, developing a rigorous standard for supply chain quality was imperative.
Cryoport Systems’ proactive strategy in implementing ISO 21973 standards across operations underscored our international reputation for operational excellence, patient safety, and scalable support. After a dedicated multi-year initiative, all Cryoport Systems’ global supply chain centers and logistics centers became fully compliant and audited under ISO 21973 standards by October 2025. The certification project strengthened our framework for global operations, reducing supply chain risk, supporting regulatory readiness, and improving reliable transportation for critical materials.
With the collaboration of our skilled team members, Cryoport Systems has advanced quality and safety standards for supply chain solutions providers in the life sciences industry. Our award-winning transportation of biological materials supports programs bringing their therapies from clinical development through commercialization.
This award speaks to the important role supply chain excellence plays in delivering potentially life-changing therapies to patients in Europe and beyond.